Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11 août 2023 16h41 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2023 (GLOBE NEWSWIRE) -- August 11, 2023—Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement...
Science 37 Reports Second Quarter 2023 Financial Results
08 août 2023 06h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...
Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
25 juil. 2023 06h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial...
Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
11 juil. 2023 07h59 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ has been chosen by Synlogic, (Nasdaq:...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
07 juil. 2023 16h52 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
09 juin 2023 16h51 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"
18 mai 2023 07h59 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, has been named the winner of the...
Science 37 Reports First Quarter 2023 Financial Results
15 mai 2023 06h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the...
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
05 mai 2023 16h53 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards...
Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot
02 mai 2023 07h59 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading MetasiteTM, today announced its partnership with the Digital Medicine...